Intelligent Patient-Controlled Medication Management System

A next-generation, wearable/implantable/ingestible medication management system that integrates real-time monitoring, AI-driven dosing, and blockchain-based tracking to prevent diversion and ensure personalized treatment plans.

The original patient-controlled liquid oral medicine dispenser and deactivation system, while addressing invasive medication administration, still has limitations in terms of patient adherence, diversion risk, and lack of real-time monitoring. The new inventive concept addresses these limitations by introducing a wearable/implantable/ingestible device that monitors medication adherence, adjusts dosing in real-time, and communicates with a cloud-based server to receive personalized treatment plans and send adherence data.

The intelligent patient-controlled medication management system comprises a wearable, implantable, or ingestible device that continuously monitors a patient's medication adherence and adjusts dosing in real-time based on personalized treatment plans received from a cloud-based server. The device is equipped with sensors and machine learning algorithms to detect potential diversion events and alert healthcare providers. Additionally, the system includes a micro-needle array for transdermal medication delivery, with a sensor to detect skin impedance and adjust needle depth accordingly. The system also utilizes decentralized, blockchain-based medication tracking and authentication, generating a unique, tamper-evident identifier for each dispensed dose.

The new inventive concept introduces a paradigm shift in patient-controlled medication management by integrating real-time monitoring, AI-driven dosing, and blockchain-based tracking, which is not obvious from the original patent. The wearable/implantable/ingestible device, micro-needle array, and decentralized tracking system are novel components that enable a more efficient, secure, and personalized medication management experience.

Alternative embodiments of the inventive concept could include varying wearable/implantable/ingestible device designs, different machine learning algorithms for diversion risk prediction, and integration with existing healthcare infrastructure. Variations could also include different types of medications, patient populations, and treatment plans.

The intelligent patient-controlled medication management system has significant commercial potential in the healthcare industry, particularly in the areas of chronic disease management, medication adherence, and pharmaceutical supply chain security. The system could be marketed to healthcare providers, pharmaceutical companies, and patients, offering a more efficient, secure, and personalized medication management experience.